Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-Methylumbelliferone in Chronic HBV and HCV
NCT00225537Phase 2Unknown
- Sponsor
- MTmedical Institute of Health
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hymecromone in Chronic Hepatitis B (CHB), hepatitis C (HCV), sponsored by MTmedical Institute of Health. Status: unknown.
02
Drugs
hymecromone
03
Conditions
Chronic Hepatitis B (CHB)hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00225537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225537.